CD274 and non-small cell lung carcinoma: For instance, the neutrophil-to-lymphocyte ratio (NLR) has been identified as a prognostic predictor for non-small-cell lung cancer (NSCLC) patients receiving combined immunotherapy and chemotherapy, regardless of PD-L1 expression (10).